Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 21, 2011 - Issue 12
Submit an article Journal homepage
194
Views
5
CrossRef citations to date
0
Altmetric
Patent Evaluations

A novel DP2 receptor antagonist (AM-461): a patent evaluation of WO2011085033

Peter Norman Norman Consulting, 18 Pink Lane, Burnham, Bucks, SL1 8JW, [email protected]
, MBA PhD
Pages 1931-1936 | Published online: 15 Nov 2011

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Giancarlo Marone, Maria Rosaria Galdiero, Antonio Pecoraro, Valentina Pucino, Gjada Criscuolo, Maria Triassi & Gilda Varricchi. (2019) Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives. Expert Opinion on Investigational Drugs 28:1, pages 73-84.
Read now
Giuseppe Santini, Nadia Mores, Mario Malerba, Chiara Mondino, Giuseppe Macis & Paolo Montuschi. (2016) Investigational prostaglandin D2 receptor antagonists for airway inflammation. Expert Opinion on Investigational Drugs 25:6, pages 639-652.
Read now
Peter Norman. (2014) Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs. Expert Opinion on Investigational Drugs 23:1, pages 55-66.
Read now
Christina Lamers, Daniel Flesch, Manfred Schubert-Zsilavecz & Daniel Merk. (2013) Novel prostaglandin receptor modulators: a patent review (2002 – 2012) – part I: non-EP receptor modulators. Expert Opinion on Therapeutic Patents 23:1, pages 47-77.
Read now

Articles from other publishers (1)

Huihui Ti, Yang Zhou, Xue Liang, Runfeng Li, Ke Ding & Xin Zhao. (2019) Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs). Journal of Medicinal Chemistry 62:13, pages 5944-5978.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.